Northrop Grumman Announces Date for Third Quarter 2025 Financial Results and Webcast

Northrop Grumman Announces Date for Third Quarter 2025 Financial Results and Webcast

Northrop Grumman Corporation (NYSE: NOC) announced today that its third quarter 2025 financial results will be released on Tuesday, October 21, 2025, prior to the market opening. The earnings announcement, and accompanying earnings presentation, will be available on the company's website at http:investor.northropgrumman.com .

Earnings Call Webcast

The company will host a live, audio only, earnings call webcast at 9:30 a.m. ET the same day. This webcast can be accessed on the company's website at http://investor.northropgrumman.com . A replay of the webcast will be available shortly after the call and will remain available for a limited time.

About Northrop Grumman
Northrop Grumman is a leading global aerospace and defense technology company. Our pioneering solutions equip our customers with the capabilities they need to connect and protect the world, and push the boundaries of human exploration across the universe. Driven by a shared purpose to solve our customers' toughest problems, our employees define possible every day.

Contact: newsbureau@ngc.com
Todd Ernst (Investors)
todd.ernst@ngc.com

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

NOC
The Conversation (0)
TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins

TSX VENTURE COMPANIES BULLETIN V2024-0267 ADVANCE LITHIUM CORP. ("AALI.H") [formerly Advance Lithium Corp. ("AALI") BULLETIN TYPE: Transfer and New Addition to NEX, Symbol Change, Remain Suspended BULLETIN DATE: January 25, 2024 TSX Venture Tier 2 Company In accordance with TSX Venture Policy... Keep Reading...

Next Super Stocks on the Move: Tetra Bio-Pharma, Red Light Holland, FansUnite, and Skylight Health

Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK livestream investor conferences, and investor "LiveChats" on social media streams. Over 170,000... Keep Reading...
Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada’s First Generic Thyroid Medication

Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada’s First Generic Thyroid Medication

Genix Pharmaceuticals Corporation (TSXV: GENX) (“GENIX” or the “Company“) is pleased to announce that it has entered into an exclusive Canadian licensing and supply agreement (the “Agreement”) with Acme Generics LLP (“ACME”) for the manufacture, sale, marketing and distribution of Canada’s first... Keep Reading...

Latest Press Releases

Related News